Norovirus Vaccine Information

Takeda Highlights Data from Clinical Trial of Investigational Norovirus Vaccine Candidate (note that clinical trial endpoint of reduction of incidence of acute gastroenteritis of any severity was not met.)
This “Virus Like Particle (VLP)” vaccine is being pre-marketed to physicians as a means to reduce the severity of disease.